What is Monte Rosa Therapeutics, Inc.'s other receivables?

Monte Rosa Therapeutics, Inc. (GLUE) reported other receivables of $4.61M in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s other receivables changed year-over-year?

Monte Rosa Therapeutics, Inc.'s other receivables increased by 227.3% year-over-year, from $1.41M to $4.61M.

What does other receivables mean?

This represents miscellaneous claims for cash or other assets not classified under standard trade accounts receivable. It often includes tax refunds, interest receivables, or non-core operational claims. Monitoring this helps identify potential hidden liquidity issues or delays in cash conversion.

Monte Rosa Therapeutics, Inc. GLUE Other Receivables

Other Receivables at other companies

Ryan Specialty HoldingsRYAN

$28.78M+16.5%

Alignment HealthcareALHC

$15.61M-15.4%

Atmus Filtration TechnologiesATMU

$6.8M—

PennyMac Financial Services, Inc.PFSI

$17.5M-40.1%

SSR MiningSSRM

$4.66M+98.6%

ADTRAN Holdings, Inc.ADTN

$10.29M+7.1%

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.76B+361%

Enterprise value$1.64B+381%

P/S41×+38.6×

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherReceivables.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s other receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s other receivables?: Monte Rosa Therapeutics, Inc. (GLUE) reported other receivables of $4.61M in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s other receivables changed year-over-year?: Monte Rosa Therapeutics, Inc.'s other receivables increased by 227.3% year-over-year, from $1.41M to $4.61M.
What does other receivables mean?: This represents miscellaneous claims for cash or other assets not classified under standard trade accounts receivable. It often includes tax refunds, interest receivables, or non-core operational claims. Monitoring this helps identify potential hidden liquidity issues or delays in cash conversion.